● Recruiting

Treprostinil in Newborns With Pulmonary Hypertension; a Non-Interventional Study to Collect Data on Drug Utilization, Safety, and Effectiveness

Condition: Persistent Pulmonary Hypertension of Newborn · Sponsor: Ferrer Internacional S.A.

PhaseN/A

Planned participants60

Who can joinAll sexes, N/A to 44 Weeks

Healthy volunteersNo

About this study

This observational study will seek to describe the uses and safety and efficacy outcomes of treprostinil in clinical practice in patients with persistent pulmonary hypertension (PPHN).

This description comes directly from the study's public registry record.

Talk to the study team

Ferrer MedInfo · 609850565 · medinfo@ferrer.com

Always discuss trial participation with your own doctor first.

Locations (4)

CHU Lyon (HCL) - Hopital Femme Mère Enfant	Bron, France	Recruiting
Réanimation néonatale CHU Grenoble Alpes - Hôpital Couple Enfant	Grenoble, France	Recruiting
CHU Lille - Clinique de Néonatalogie	Lille, France	Recruiting
CHU de Toulouse Hopital des enfants - Réanimation Néonatale	Toulouse, France	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06499363